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Purpose: In proton therapy a generic relative biological 
effectiveness (RBE) of 1.1 has traditionally been clinically 
applied, implying that protons are slightly more effective 
than photons. However, there exist large amounts of data, 
mainly from in vitro studies, demonstrating that the RBE is 
variable and dependent on a set of factors, including the 
radiation quality of the beam. Most of the phenomenological 
models made for estimating the RBE use the dose average 
Linear Energy Transfer (LETd) as a parameter for the 
radiation quality. However, such a simplified description of 
the quality might lead to inaccurate RBE. In this work a new 
RBE model for proton therapy has been developed, utilizing 
the dose weighted LET spectrum (d(L)) to describe the 
radiation quality.  
Materials/methods: A new formalism for RBE calculation is 
introduced, based on the concept of RBEmax and the usage of 
biological weighting functions. RBEmax is found by weighting 
the LET spectrum by rmax(L), a smooth continuous function for 
the full LET range of protons (0-83 keV/μm). We assumed 
that rmax(L) is nonlinear and symmetric around a turnover 
point (LETu). A quantitative description of rmax(L) was found 
by making a regression fit to the α/αx of 96 data points, 
where the α and αx are coefficients of the linear-quadratic 
model, for proton and photon irradiation respectively. These 
points were extracted from experiments with semi-
monoenergetic proton beams found in literature. In our 
model we have assumed that β = βx and thus RBEmin = 1. A 
Fluka Monte Carlo simulation was done to check the new 
calculation method was benchmarked against a constant RBE 
of 1.1 and an existing LETd based model for variable RBE 
(McNamara et al., 2015). 
Results: By fitting rmax(L) to the data, we found a peak at 
LETu=34.5 keV/μm. The fit had a R2 value of 0.634. In the 
simulated example, the new model estimated a RBE of 1.00-
1.02 in the entrance region. The RBE rises from 1.05 to 1.6 
along the SOBP. This indicates that a constant RBE of 1.1 
leads to an overestimate of the dose to the normal tissue, as 
well to the proximal part of the tumour. Compared to the 
LETd based model, the RBE is approximately 9-11% lower at 
all depths.  
Conclusions: A dose and tissue dependent RBE model, based 
on the LET spectrum has been developed for application in 
proton therapy. Compared to LETd–based model, this 
approach might give a better estimation of the biological 
dose in a mixed radiation field. The model could be further 
optimized, by adjusting the definition of rmax(L) and 
introducing a term for rmin(L), taking into account a variable 
LET dependent β parameter. 
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Purpose: The growing interest in charged particle therapy 
has led to the development of dedicated systems able to 
monitor the dose delivered to the patient. Positron Emission 
Tomography (PET) is a non-invasive way for in-vivo 
verification of the dose delivery. In fact, during particle 
irradiation, various ß
+
-emitting isotopes (15O, 11C etc.) are 
generated in the patient and this activity distribution can be 
related to the delivered dose. 
Materials/methods: A compact PET system was developed to 
be installed close to the patient. The PET system, DoPET, is 
based on two planar heads. Over the years the dimension of 
the heads was increased, from 5cm x 5cm, to 10cm x10cm 
and finally to the dimension of 15cm x 15cm per head. The 
heads result from the assembly of several detecting 
modules: in the present prototype there are 9 modules (3x3) 
per head. Each detecting module, (5cm x 5cm) consists of 
a segmented LYSO crystal matrix (2 mm pitch) coupled to a 
PSPMT. The readout is performed by custom electronics, and 
the data acquisition was designed to cope with the high 
fluxes present during the treatment plan (TP) delivery. The 
data reconstruction of the measured 3-D ß
+
-activity 
distribution, based on a MLEM-OSEM 3D algorithm takes less 
than one minute. 
The system was mostly characterized for proton therapy 
applications: at CATANA, a cyclotron-based center(LNS-
INFN Catania, Italy), and at CNAO a synchrotron-based 
center (Pavia, Italy). Preliminary characterization for 
carbon irradiations were also performed. 
Results: The DoPET spatial resolution guarantees the 
reconstruction of the distal fall activity profile with a 
sensibility of 1 mm, operating in-treatment [1, 2]. The in-
treatment data were useful. In fact, DoPET provided 
information on a whole protonTP and on its very early 
phases [3]. A study was done delivering only the proton TP 
Highest Energy Layer: thanks to the sharp shape of the 
mono-energetic activity fall- off profile, the shift due to 
the presence of a small air cavity was evident. 
The experimental ß
+
-activity profiles were also compared to 
calculated data obtained with FLUKA Monte Carlo, with very 
satisfactory agreement [3]. 
Conclusions: DoPET represents a reliable and fast in-
treatment monitoring system that could act as an image 
guidance in the case of hypo-fractionation scheme. The 
present head dimension allows studies with anthropomorphic 
phantoms that will be done before moving onto patients. 
 
Keywords: Particle therapy monitoring, on-line PET  
References: 
[1] N. Camarlinghi et al. An In-beam PET System For 
Monitoring Ion-beam Therapy: Test On Phantoms Using 
Clinical 62 MeV Protons; JINST 9 C04005 (2014) 1-12 
[2] G. Sportelli et al. First full-beam PET acquisitions in 
proton therapy with a modular dual-head dedicated system; 
Phys. Med. Biol. 59 (2014) 43–60; 
[3] A.C. Kraan et al. First tests for an on line treatment 
monitoring system with in-beam PET for proton therapy; 
JINST, 10, C01010 (2015) 1-11 
 
 
 
 
189 
Design of an innovative beam monitor for particle therapy 
for the simultaneous measurement of beam fluence and 
energy  
R. Sacchi1,2, N.Cartiglia1, F. Cenna1, L. Fanola1,2, M. Ferrero2, 
S. Giordanengo1, F. Marchetto1, V. Monaco1,2, A. Vignati1, M. 
Varasteh Anvar1,2, R. Cirio1,2 
1 Istituto Nazionale di Fisica Nucleare (INFN), division of 
Torino, Torino, Italy 
2 Department of Physics, University of Torino, Torino, Italy 
 
